Ausgabe 1/2017
Inhalt (24 Artikel)
DNA topoisomerase-targeting chemotherapeutics: what’s new?
Selma M. Cuya, Mary-Ann Bjornsti, Robert C.A.M. van Waardenburg
Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles?
Kuhan Kunarajah, Stefanie Hennig, Ross L. G. Norris, Michael Lobb, Bruce G. Charles, Ross Pinkerton, Andrew S. Moore
Erratum to: Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles?
Kuhan Kunarajah, Stefanie Hennig, Ross L. G. Norris, Michael Lobb, Bruce G. Charles, Ross Pinkerton, Andrew S. Moore
Pharmacokinetics and safety of vismodegib in patients with advanced solid malignancies and hepatic impairment
Ghassan K. Abou-Alfa, Lionel D. Lewis, Patricia LoRusso, Michael Maitland, Priya Chandra, Sravanthi Cheeti, Dawn Colburn, Sarah Williams, Brian Simmons, Richard A. Graham
The renal safety and efficacy of combined gemcitabine plus cisplatin and gemcitabine plus carboplatin chemotherapy in Chinese patients with a solitary kidney after nephroureterectomy
Peng Sun, Cong Xue, Li-Ren Li, Cui Shao, Xin An, Ried Thomas, Wei Yang, Ying-Fei Deng, Wen-Qi Jiang, Yan-Xia Shi
Estimation of glomerular filtration rate in cancer patients with abnormal body composition and relation with carboplatin toxicity
M. Bretagne, A. Jouinot, J. P. Durand, O. Huillard, P. Boudou Rouquette, C. Tlemsani, J. Arrondeau, G. Sarfati, F. Goldwasser, J. Alexandre
Possible involvement of the lipoxygenase and leukotriene signaling pathways in cisplatin-mediated renal toxicity
Osama A. Alkhamees, Abdulaziz S. Alroujayee, Hatem M. Abuohashish, Fatima S. Alrojayee, Mohammed M. Ahmed
Is there any predictor for hypersensitivity reactions in gynecologic cancer patients treated with paclitaxel-based therapy?
Tadashi Aoyama, Masashi Takano, Morikazu Miyamoto, Tomoyuki Yoshikawa, Hiroaki Soyama, Kento Kato, Hiroki Ishibashi, Hideki Iwahashi, Masaya Nakatsuka, Isao Yajima, Yukihiro Shimizu, Yusuke Aizawa, Yuki Suguchi, Miki Moriiwa, Tomoko Goto, Hidenori Sasa, Isao Nagaoka, Hitoshi Tsuda, Kenichi Furuya
Cellular effect and efficacy of carfilzomib depends on cellular net concentration gradient
Julia Schäfer, Lukas Welti, Anja Seckinger, Jürgen Burhenne, Dirk Theile, Johanna Weiss
Phase I/II study of bi-weekly XELIRI plus bevacizumab treatment in patients with metastatic colorectal cancer resistant to oxaliplatin-based first-line chemotherapy
Tsunekazu Mizushima, Mutsumi Fukunaga, Toshinori Sueda, Masataka Ikeda, Takeshi Kato, Ho Min Kim, Toshihiro Kudo, Kohei Murata, Junichi Nishimura, Taishi Hata, Chu Matsuda, Hirofumi Yamamoto, Yuichiro Doki, Masaki Mori
The cardiac glycoside oleandrin induces apoptosis in human colon cancer cells via the mitochondrial pathway
Li Pan, Yuming Zhang, Wanlu Zhao, Xia Zhou, Chunxia Wang, Fan Deng
Prognostic value of chemotherapy-resistant CK19mRNA-positive circulating tumor cells in patients with advanced/metastatic non-small cell lung cancer
G. Milaki, I. Messaritakis, F. Koinis, A. Kotsakis, S. Apostolaki, E. K. Dermitzaki, M. Perraki, D. Hatzidaki, V. Georgoulias
ABCC4 functional SNP in the 3′ splice acceptor site of exon 8 (G912T) is associated with unfavorable clinical outcome in children with acute lymphoblastic leukemia
Hamzeh Mesrian Tanha, Soheila Rahgozar, Marjan Mojtabavi Naeini
Prospective multicenter phase II study of gemcitabine plus cisplatin in patients with unresectable gallbladder cancer
Yoshiki Hirooka, Takuya Ishikawa, Hiroki Kawashima, Eizaburo Ohno, Koji Nonogaki, Akira Kanamori, Takanori Hirai, Hiroki Uchida, Osamu Shirai, Hideki Ishikawa, Hidemi Goto
Allred score is a promising predictor of prognosis and medroxyprogesterone acetate efficacy in patients with endometrial cancer
Mayu Yunokawa, Hiroshi Yoshida, Reiko Watanabe, Emi Noguchi, Akihiko Shimomura, Tatsunori Shimoi, Kan Yonemori, Chikako Shimizu, Yasuhiro Fujiwara, Kenji Tamura
UGT1A1*6 polymorphisms are correlated with irinotecan-induced neutropenia: a systematic review and meta-analysis
Xue Zhang, Jia-Fu Yin, Jiao Zhang, Shu-Jia Kong, Hong-Yin Zhang, Xue-Mei Chen
βIII-tubulin enhances efficacy of cabazitaxel as compared with docetaxel
Gregoriy Smiyun, Olga Azarenko, Herbert Miller, Alexander Rifkind, Nichole E. LaPointe, Leslie Wilson, Mary Ann Jordan
Population pharmacokinetic analyses of the effect of carboplatin pretreatment on olaparib in recurrent or refractory women’s cancers
Cody J. Peer, Jung-Min Lee, Jeffrey Roth, Louis Rodgers, Jeffers Nguyen, Christina M. Annunziata, Lori Minasian, Elise C. Kohn, William D. Figg
Differential expression pattern of protein markers for predicting chemosensitivity of dexamethasone-based chemotherapy of B cell acute lymphoblastic leukemia
Nasrin Dehghan-Nayeri, Peyman Eshghi, Kourosh Goudarzi Pour, Mostafa Rezaei-Tavirani, Mir Davood Omrani, Ahmad Gharehbaghian
Clinical significance of systemic chemotherapy after curative resection of metachronous pulmonary metastases from colorectal cancer
Sungwoo Park, Byung Woog Kang, Soo Jung Lee, Shinkyo Yoon, Yee Soo Chae, Jong Gwang Kim, Kyung Hee Lee, Sung Ae Koh, Hong Suk Song, Keon Uk Park, Jin Young Kim, Mi Hwa Heo, Hun Mo Ryoo, Yoon Young Cho, Jungmin Jo, Jung Lim Lee, Sun Ah Lee
Phase II study of induction gemcitabine and S-1 followed by chemoradiotherapy and systemic chemotherapy using S-1 for locally advanced pancreatic cancer
Kentaro Sudo, Ryusuke Hara, Kazuyoshi Nakamura, Emiri Kita, Akiko Tsujimoto, Taketo Yamaguchi
Efficacy and safety of postoperative bio-chemoradiotherapy using cetuximab and docetaxel for high-risk head and neck cancer patients in Japan
Goshi Nishimura, Osamu Shiono, Daisuke Sano, Kenichiro Yabuki, Yasuhiro Arai, Yoshihiro Chiba, Teruhiko Tanabe, Nobuhiko Oridate
Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients
Bum Jun Kim, Jaewon Hyung, Changhoon Yoo, Kyu-pyo Kim, Seong-Joon Park, Sang Soo Lee, Do Hyun Park, Tae Jun Song, Dong Wan Seo, Sung Koo Lee, Myung-Hwan Kim, Jin-hong Park, Hyungwoo Cho, Baek-Yeol Ryoo, Heung-Moon Chang
Carfilzomib and lenalidomide response related to VEGF and VEGFR2 germline polymorphisms
Tristan M. Sissung, Cody J. Peer, Neha Korde, Sham Mailankody, Dickran Kazandjian, David J. Venzon, Ola Landgren, William D. Figg